Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L T Bacheler

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Gene|January 1, 1986
Cloning and characterization of a rat-specific repetitive DNA sequenceS K Shore, L T Bacheler, J K de Riel, et al.
Journal of Medicinal Chemistry|January 17, 1997
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIVP K Jadhav, P Ala, F J Woerner, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residuesM Patel, L T Bacheler, M M Rayner, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitorsM Patel, R J McHugh, B C Cordova, et al.
Science (New York, N.Y.)|October 27, 1989
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cellsC E Hart, C Y Ou, J C Galphin, et al.
Biochemical and Biophysical Research Communications|December 30, 1994
Construction of infectious molecular clones of HIV-1 containing defined mutations in the protease geneD L Winslow, E D Anton, R A Horlick, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitorM J Otto, C D Reid, S Garber, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituentsM Patel, J D Rodgers, R J McHugh, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chainA J Cocuzza, D R Chidester, B C Cordova, et al.
AIDS Research and Human Retroviruses|November 11, 1991
Human chromosome-dependent and -independent pathways for HIV-2 trans-activationC E Hart, M A Westhafer, J C Galphin, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Gene|January 1, 1986
Cloning and characterization of a rat-specific repetitive DNA sequenceS K Shore, L T Bacheler, J K de Riel, et al.
Journal of Medicinal Chemistry|January 17, 1997
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIVP K Jadhav, P Ala, F J Woerner, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residuesM Patel, L T Bacheler, M M Rayner, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitorsM Patel, R J McHugh, B C Cordova, et al.
Science (New York, N.Y.)|October 27, 1989
Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cellsC E Hart, C Y Ou, J C Galphin, et al.
Biochemical and Biophysical Research Communications|December 30, 1994
Construction of infectious molecular clones of HIV-1 containing defined mutations in the protease geneD L Winslow, E D Anton, R A Horlick, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1993
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitorM J Otto, C D Reid, S Garber, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituentsM Patel, J D Rodgers, R J McHugh, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chainA J Cocuzza, D R Chidester, B C Cordova, et al.
AIDS Research and Human Retroviruses|November 11, 1991
Human chromosome-dependent and -independent pathways for HIV-2 trans-activationC E Hart, M A Westhafer, J C Galphin, et al.
Pageof 4